Poseida Therapeutics, Inc.

NASDAQ:PSTX

3.28 (USD) • At close November 13, 2024
Overzicht | Financiële gegevens

Cijfers zijn in miljoenen (behalve de cijfers per aandeel en de ratio's) USD.

2024 Q32024 Q22024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q32020 Q22020 Q12019 Q42019 Q32019 Q22019 Q12018 Q42017 Q4
Omzet 71.74825.97328.14224.9959.35220.01310.3439.921116.3062.71.4350.0310000000000000
Kosten van de omzet 01.3491.384.1761.4441.4081.3241.3551.351.261.2070.0311.1691.1281.072103.52000000000
Brutowinst 71.74824.62426.76220.8197.90818.6059.0198.566114.9561.440.2280-1.169-1.128-1.072-103.52000000000
Brutowinstmarge 10.9480.9510.8330.8460.930.8720.8630.9880.5330.1590.0010000000000000
Onderzoek- en ontwikkelingskosten 41.91444.19841.54142.04637.48239.19238.05233.90435.13735.00848.850.03932.52436.00829.0950.02827.01625.2123.41419.20415.69616.8818.6139.7534.354
Algemene en administratieve kosten 10.09212.1829.7988.868.0928.67611.8079.3689.3899.2379.5460.019.0668.8718.3690.0076.4584.2364.8544.0084.0074.0426.3992.3971.595
Verkoop- en marketingkosten 0000000000000000000000000
Verkoop-, algemene en administratieve kosten 10.09212.1829.7988.868.0928.67611.8079.3689.3899.2379.5460.019.0668.8718.3690.0076.4584.2364.8544.0084.0074.0426.3992.3971.595
Overige kosten 02.6442.556-12.0246.7872.542.6972.170.6560.052-0.0190.020.0030.017-0.0120-0.092-0.090.3980.5190.7440.6190.67600
Bedrijfskosten 52.00656.3851.33950.90645.57447.86849.85943.27244.52644.24558.3960.04941.5944.87937.4640.03533.47429.44628.26823.21219.70320.92315.01212.2554.8
Bedrijfsresultaat 19.742-31.756-24.577-25.911-36.222-27.855-39.516-33.22171.78-41.545-56.961-0.017-41.59-44.879-37.464-0.035-33.474-29.446-28.268-23.212-20.763-28.343-13.215-12.15-5.949
Bedrijfsresultaat ratio 0.275-1.223-0.873-1.037-3.873-1.392-3.821-3.3490.617-15.387-39.694-0.560000000000000
Totaal overige inkomsten en kosten netto 0.5360.3850.3030.564.5510.3990.6690.195-1.119-1.491-1.09618.947-0.834-0.826-0.85-0.788-0.94-0.982-0.516-0.401-1.251-7.7041.678-0.7340.819
Inkomen voor belasting 20.278-31.371-24.274-25.349-31.671-27.456-38.847-33.02670.661-43.036-58.0570.001-42.424-45.705-38.314-0.036-34.414-30.428-28.784-23.613-20.954-28.627-13.334-12.884-5.13
Inkomen voor belasting ratio 0.283-1.208-0.863-1.014-3.387-1.372-3.756-3.3290.608-15.939-40.4580.0470000000000000
Belastingkosten -0.04301.337-6.04-0.1074.6811.3590.2920.2521.4911.096-17.6020.840.860.826-1.0390.7560.8021.3121.4391.6791.5221.4710.0060.339
Nettowinst 20.235-31.371-24.274-23.99-31.778-27.456-40.206-33.31870.409-44.527-59.1530.001-42.424-45.705-38.314-0.036-34.414-30.428-28.784-23.613-20.954-28.627-13.334-12.89-4.791
Nettowinstmarge 0.282-1.208-0.863-0.96-3.398-1.372-3.887-3.3580.605-16.491-41.2220.0470000000000000
WPA (Winst Per Aandeel) 0.21-0.32-0.25-0.27-0.35-0.32-0.47-0.390.92-0.71-0.950.02-0.68-0.74-0.62-0.001-0.63-0.53-0.5-0.59-0.53-0.72-0.34-1.05-0.41
Verwaterde WPA 0.21-0.32-0.25-0.27-0.35-0.32-0.47-0.390.92-0.71-0.950.02-0.68-0.74-0.62-0.001-0.63-0.53-0.5-0.59-0.53-0.72-0.34-1.05-0.41
EBITDA 19.742-27.763-20.641-21.644-27.991-23.907-35.495-29.69673.786-40.233-55.7733.492-40.418-43.734-36.404-34.256-32.879-29.093-27.454-22.307-19.672-27.465-12.338-11.997-5.775
EBITDA ratio 0.275-1.171-0.824-1.848-3.873-1.195-3.56-3.130.634-14.901-38.8660.0740000000000000